moxifloxacin has been researched along with Kidney Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, J; Huo, N; Li, J; Li, Y; Lin, X; Tian, G; Wan, H; Wang, G; Wang, Y; Yang, X; Zhao, H | 1 |
| Bührmann, S; Kribben, A; Kubitza, D; Mitchell, A; Möller, JG; Schäfers, RF; Stass, H; Wenzel, RR | 1 |
| Iannini, PB | 1 |
1 review(s) available for moxifloxacin and Kidney Diseases
| Article | Year |
|---|---|
The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Cardiovascular Diseases; Fluoroquinolones; Glucose; Homeostasis; Humans; Kidney Diseases; Liver Diseases; Metabolic Diseases; Moxifloxacin; Population Groups; Quinolines; Risk Factors | 2007 |
2 other study(ies) available for moxifloxacin and Kidney Diseases
| Article | Year |
|---|---|
Renal abscess caused by Brucella.
Topics: Abscess; Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Drug Therapy, Combination; Fluoroquinolones; Humans; Kidney Diseases; Male; Middle Aged; Minocycline; Moxifloxacin; Rifampin | 2014 |
The influence of continuous venovenous haemodialysis on the pharmacokinetics of multiple oral moxifloxacin administration to patients with severe renal dysfunction.
Topics: Administration, Oral; Adult; Aza Compounds; Drug Administration Schedule; Female; Fluoroquinolones; Hemofiltration; Humans; Kidney Diseases; Male; Metabolic Clearance Rate; Moxifloxacin; Quinolines; Renal Dialysis | 2007 |